JRI
Nuveen Real Asset Income and Growth Fund [JRI] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
JRI Stock Summary
Top 10 Correlated ETFs
JRI
Top 10 Correlated Stocks
JRI
In the News
JRI Financial details
Company Rating
Buy
Market Cap
304.6M
Income
-40.87M
Revenue
31.11M
Book val./share
13.69
Cash/share
0.74
Dividend
1.08
Dividend %
9.02%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
-4.45
Forward P/E
-
PEG
0.99
P/S
-4.57
P/B
0.88
P/C
14.81
P/FCF
6.01
Quick Ratio
4.31
Current Ratio
4.31
Debt / Equity
0.41
LT Debt / Equity
0.4
-
-
EPS (TTM)
-1.48
EPS next Y
-
EPS next Q
-
EPS this Y
-144.78%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-24.37%
Revenue last 5Y
-35.95%
Revenue Q/Q
713.55%
EPS Q/Q
60.87%
-
-
-
-
SMA20
-8.33%
SMA50
-8.33%
SMA100
-
Inst Own
29.08%
Inst Trans
1%
ROA
-13%
ROE
-17%
ROC
-0.13%
Gross Margin
100%
Oper. Margin
97%
Profit Margin
103%
Payout
-43%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.7-12.12
52W High
-8.67%
52W Low
+21.78%
RSI
32
Rel Volume
0.93
Avg Volume
70.54K
Volume
65.46K
Perf Week
-3.52%
Perf Month
-5.44%
Perf Quarter
12.87%
Perf Half Y
6.72%
-
-
-
-
Beta
1.18238
-
-
Volatility
0.07%, 0.3%
Prev Close
0.46%
Price
10.96
Change
0%
JRI Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 4.93 | -2.92 | 2.8 | -2.61 | 0.53 | |
| Net income per share | 4.85 | -2.99 | 2.73 | -2.68 | 1.2 | |
| Operating cash flow per share | -1.13 | 5.62 | -0.09 | 1.99 | 0.8 | |
| Free cash flow per share | -1.13 | 5.62 | -0.09 | 1.99 | 0.8 | |
| Cash per share | 0.54 | 0.65 | 0.85 | 0.8 | 0.74 | |
| Book value per share | 20.04 | 15.84 | 17.41 | 13.57 | 13.69 | |
| Tangible book value per share | 20.04 | 15.84 | 17.41 | 13.57 | 13.69 | |
| Share holders equity per share | 20.04 | 15.84 | 17.41 | 13.57 | 13.69 | |
| Interest debt per share | 10.7 | 6.15 | 7.27 | 6.24 | 5.94 | |
| Market cap | 504.33M | 369.53M | 442.55M | 321.21M | 321.32M | |
| Enterprise value | 723.96M | 534.04M | 638.08M | 487.93M | 474.82M | |
| P/E ratio | 3.78 | -4.5 | 5.9 | -4.36 | 9.8 | |
| Price to sales ratio | 3.73 | -4.61 | 5.75 | -4.48 | 22.01 | |
| POCF ratio | -16.31 | 2.39 | -184.95 | 5.89 | 14.73 | |
| PFCF ratio | -16.31 | 2.39 | -184.95 | 5.89 | 14.73 | |
| P/B Ratio | 0.92 | 0.85 | 0.93 | 0.86 | 0.86 | |
| PTB ratio | 0.92 | 0.85 | 0.93 | 0.86 | 0.86 | |
| EV to sales | 5.35 | -6.66 | 8.29 | -6.81 | 32.53 | |
| Enterprise value over EBITDA | 5.43 | -6.51 | 8.51 | -7.04 | 11.02 | |
| EV to operating cash flow | -23.42 | 3.46 | -266.66 | 8.95 | 21.77 | |
| EV to free cash flow | -23.42 | 3.46 | -266.66 | 8.95 | 21.77 | |
| Earnings yield | 0.26 | -0.22 | 0.17 | -0.23 | 0.1 | |
| Free cash flow yield | -0.06 | 0.42 | -0.01 | 0.17 | 0.07 | |
| Debt to equity | 0.52 | 0.38 | 0.41 | 0.45 | 0.41 | |
| Debt to assets | 0.34 | 0.27 | 0.29 | 0.31 | 0.29 | |
| Net debt to EBITDA | 1.65 | -2 | 2.61 | -2.41 | 3.56 | |
| Current ratio | 4.92 | 2.08 | 2.4 | 4.31 | 0 | |
| Interest coverage | 20.25 | -29.93 | 47.38 | -15.88 | 4.66 | |
| Income quality | -0.23 | -1.88 | -0.03 | -0.74 | 0.66 | |
| Dividend Yield | 0.07 | 0.09 | 0.07 | 0.1 | 0.09 | |
| Payout ratio | 0.27 | -0.41 | 0.42 | -0.43 | 0.9 | |
| Sales general and administrative to revenue | 0.01 | -0.01 | 0.01 | -0.01 | 0.04 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 46.78 | 32.63 | 32.7 | 28.62 | 19.2 | |
| ROIC | 0.16 | -0.14 | 0.11 | -0.13 | 0.08 | |
| Return on tangible assets | 0.16 | -0.13 | 0.11 | -0.13 | 0.06 | |
| Graham Net | -9.29 | -5.33 | -6.02 | -4.82 | -4.93 | |
| Working capital | 13.34M | 4.67M | 5.17M | 5.97M | -3.03M | |
| Tangible asset value | 550.46M | 434.74M | 477.91M | 372.45M | 375.32M | |
| Net current asset value | -278.28M | -173.54M | -199.55M | -167.02M | -158.89M | |
| Invested capital | 0.52 | 0.38 | 0.41 | 0.45 | 0.41 | |
| Average receivables | 13.09M | 10.8M | 6.96M | 6.95M | 6.1M | |
| Average payables | 3.67M | 3.86M | 4.01M | 2.75M | 1.39M | |
| Average inventory | 14.46M | 27.18M | 27.6M | 29.63M | 14.75M | |
| Days sales outstanding | 38.13 | -33.98 | 30.61 | -37.95 | 118.97 | |
| Days payables outstanding | 160.77 | 249.01 | 206.78 | 103.27 | 65.15 | |
| Days of inventory on hand | 1.37K | 1.47K | 1.67K | 1.69K | 0 | |
| Receivables turnover | 9.57 | -10.74 | 11.92 | -9.62 | 3.07 | |
| Payables turnover | 2.27 | 1.47 | 1.77 | 3.53 | 5.6 | |
| Inventory turnover | 0.27 | 0.25 | 0.22 | 0.22 | 0 | |
| ROE | 0.24 | -0.19 | 0.16 | -0.2 | 0.09 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0.73 | -0.13 | 0.06 | 0.47 | |
| Net income per share | 0 | -2.2 | -0.48 | 0.46 | 0.74 | |
| Operating cash flow per share | 0 | 0.39 | 0.4 | 0.35 | 0.45 | |
| Free cash flow per share | 0 | 0.39 | 0.4 | 0.35 | 0.45 | |
| Cash per share | 0 | 0.88 | 0.8 | 0.92 | 0.74 | |
| Book value per share | 0 | 14.63 | 13.57 | 13.49 | 13.69 | |
| Tangible book value per share | 0 | 14.63 | 13.57 | 13.49 | 13.69 | |
| Share holders equity per share | 0 | 14.63 | 13.57 | 13.49 | 13.69 | |
| Interest debt per share | 0 | 6.99 | 6.2 | 5.93 | 5.78 | |
| Market cap | 0 | 358.82M | 321.21M | 313.1M | 321.32M | |
| Enterprise value | 195.52M | 544.38M | 487.93M | 470.67M | 474.82M | |
| P/E ratio | 0 | -1.49 | -6.03 | 6.24 | 3.97 | |
| Price to sales ratio | 0 | 17.81 | -88.42 | 195.96 | 24.72 | |
| POCF ratio | 0 | 33.19 | 29.31 | 33.07 | 26.04 | |
| PFCF ratio | 0 | 33.19 | 29.31 | 33.07 | 26.04 | |
| P/B Ratio | 0 | 0.89 | 0.86 | 0.85 | 0.86 | |
| PTB ratio | 0 | 0.89 | 0.86 | 0.85 | 0.86 | |
| EV to sales | 0 | 27.02 | -134.31 | 294.58 | 36.53 | |
| Enterprise value over EBITDA | 0 | -9.2 | -48.16 | 27.58 | 18.25 | |
| EV to operating cash flow | 0 | 50.35 | 44.53 | 49.71 | 38.48 | |
| EV to free cash flow | 0 | 50.35 | 44.53 | 49.71 | 38.48 | |
| Earnings yield | 0 | -0.17 | -0.04 | 0.04 | 0.06 | |
| Free cash flow yield | 0 | 0.03 | 0.03 | 0.03 | 0.04 | |
| Debt to equity | 0.41 | 0.48 | 0.45 | 0.43 | 0.41 | |
| Debt to assets | 0.29 | 0.31 | 0.31 | 0.29 | 0.29 | |
| Net debt to EBITDA | 0 | -3.14 | -16.45 | 9.23 | 5.9 | |
| Current ratio | 2.4 | 1.29 | 4.31 | 2.52 | 0 | |
| Interest coverage | 0 | -50.03 | -3.18 | 3.78 | 5.51 | |
| Income quality | 0 | -0.18 | -0.82 | 0.75 | 0.61 | |
| Dividend Yield | 0 | 0.04 | 0.06 | 0.04 | 0.05 | |
| Payout ratio | 0 | -0.22 | -1.39 | 1 | 0.84 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 26.9 | 12.17 | 11.78 | 15.08 | |
| ROIC | 0 | -0.1 | -0.02 | 0.03 | 0.05 | |
| Return on tangible assets | 0 | -0.1 | -0.02 | 0.02 | 0.04 | |
| Graham Net | 0 | -6.23 | -4.82 | -4.37 | -4.93 | |
| Working capital | 5.17M | 3.12M | 5.97M | 4.38M | -3.03M | |
| Tangible asset value | 477.91M | 401.66M | 372.45M | 369.73M | 375.32M | |
| Net current asset value | -199.55M | -191.67M | -167.02M | -159.26M | -158.89M | |
| Invested capital | 0.41 | 0.48 | 0.45 | 0.43 | 0.41 | |
| Average receivables | 10.79M | 10.13M | 10.62M | 7.26M | 5.92M | |
| Average payables | 6.56M | 7.19M | 6.24M | 2.34M | 1.93M | |
| Average inventory | 0 | 0 | 14.75M | 30.86M | 16.11M | |
| Days sales outstanding | 0 | 61.64 | -184.5 | 398.93 | 32.94 | |
| Days payables outstanding | 0 | 286.39 | 53.87 | 90.85 | 33.27 | |
| Days of inventory on hand | 0 | 0 | 881.81 | 1.02K | 0 | |
| Receivables turnover | 0 | 1.46 | -0.49 | 0.23 | 2.73 | |
| Payables turnover | 0 | 0.31 | 1.67 | 0.99 | 2.71 | |
| Inventory turnover | 0 | 0 | 0.1 | 0.09 | 0 | |
| ROE | 0 | -0.15 | -0.04 | 0.03 | 0.05 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
JRI Frequently Asked Questions
What is Nuveen Real Asset Income and Growth Fund stock symbol ?
Nuveen Real Asset Income and Growth Fund is a US stock , located in Chicago of Il and trading under the symbol JRI
What is Nuveen Real Asset Income and Growth Fund stock quote today ?
Nuveen Real Asset Income and Growth Fund stock price is $10.96 today.
Is Nuveen Real Asset Income and Growth Fund stock public?
Yes, Nuveen Real Asset Income and Growth Fund is a publicly traded company.
Company Profile
- Volume Average 70.54K
- Market Capitalization 304.6M
- CEO Mr. John G. Wenker
- Headquarters Chicago,IL,US
- IPO Date 2012-04-27
-
Website
https://www.nuveen.com/cef/Product/Overview.aspx?fundcode=JRI 
Nuveen Real Asset Income and Growth Fund is an closed ended balanced mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the public equity markets across the globe. The fund also makes its investments in depository receipts. It invests in stocks of companies operating in real estate sector. For the fixed income portion of its portfolio the fund invest in investment grade quality rated BB+/Ba1 or lower. Nuveen Real Asset Income and Growth Fund was formed on April 25, 2012 and is domiciled in the United States.
